What is LOPJLB’s current signal on ABP?

LOPJLB’s latest quantitative signal on Abpro Corporation (ABP) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is ABP in?

Abpro Corporation (ABP) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Abpro Corporation (ABP) do?

Abpro Holdings, Inc. is a biotechnology firm dedicated to creating antibody-based treatments for patients suffering from conditions in immuno-oncology, ophthalmology, and autoimmunity. A key element of their strategy is the proprietary DiversImmune platform, which aims to resolve a significant hurdle in the antibody therapeutics sector. Their primary investigational drug candidates include ABP-…

Where is Abpro Corporation based / listed?

Abpro Corporation is based in US, listed on NASDAQ.

Abpro Corporation (ABP)

Healthcare · Biotechnology · NASDAQ · US

$0.16+14.29%Close

SELLRECOVERY · day 4

[SCORES & PROFILE]

FUND: 15
VALUE: 13
GROWTH: 35
GARP: 6
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC29.5%

REV YoY-

ROE49.2%

EPS YoY-

ROA-

GROSS

NET

[VALUATION]

P/E TTM-0.11

P/E FWD-

SECTOR PE22.62

INDUSTRY PE17.13

P/B-0.08

P/FCF-

EV/EBITDA-0.12

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO0.07

ND/EBITDA-

BETA-0.00

Abpro Corporation (ABP)

Key stats

Sector peers

Prediction markets

FUNDAMENTALS

Company news